195 related articles for article (PubMed ID: 17251312)
1. Systemic inflammation and decline in lung function in a general population: a prospective study.
Fogarty AW; Jones S; Britton JR; Lewis SA; McKeever TM
Thorax; 2007 Jun; 62(6):515-20. PubMed ID: 17251312
[TBL] [Abstract][Full Text] [Related]
2. FEV
Hart JE; Goldstein R; Walia P; Teylan M; Lazzari A; Tun CG; Garshick E
BMC Pulm Med; 2017 Aug; 17(1):113. PubMed ID: 28810847
[TBL] [Abstract][Full Text] [Related]
3. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.
Shaaban R; Kony S; Driss F; Leynaert B; Soussan D; Pin I; Neukirch F; Zureik M
Respir Med; 2006 Dec; 100(12):2112-20. PubMed ID: 16650972
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
5. Relationship between airway obstruction and C-reactive protein levels in a community-based population of Korea.
Yoo B; Lee SH; Kim SY; Leem AY; Chung KS; Kim EY; Jung JY; Kang YA; Park MS; Chang J; Kim YS; Park Y
Int J Tuberc Lung Dis; 2019 Nov; 23(11):1228-1234. PubMed ID: 31718761
[No Abstract] [Full Text] [Related]
6. Systemic inflammatory markers in relation to lung function in NHANES. 2007-2010.
Nerpin E; Jacinto T; Fonseca JA; Alving K; Janson C; Malinovschi A
Respir Med; 2018 Sep; 142():94-100. PubMed ID: 30170809
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study.
Ahmadi-Abhari S; Kaptoge S; Luben RN; Wareham NJ; Khaw KT
Am J Epidemiol; 2014 Jan; 179(1):48-56. PubMed ID: 24064740
[TBL] [Abstract][Full Text] [Related]
8. CRP is associated with lung function decline in men but not women: a prospective study.
Ólafsdóttir IS; Gíslason T; Gudnason V; Benediktsdóttir B; Ólafsson Í; Aspelund T; Thjódleifsson B; Janson C
Respir Med; 2013 Jan; 107(1):91-7. PubMed ID: 23083841
[TBL] [Abstract][Full Text] [Related]
9. The CRP genotype, serum levels and lung function in men: the Caerphilly Prospective Study.
Bolton CE; Schumacher W; Cockcroft JR; Timpson NJ; Smith GD; Gallacher J; Rumley A; Lowe GD; Ebrahim S; Shale DJ; Ben-Shlomo Y
Clin Sci (Lond); 2011 Apr; 120(8):347-55. PubMed ID: 21080913
[TBL] [Abstract][Full Text] [Related]
10. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
11. Smoking, Systemic Inflammation, and Airflow Limitation: A Mendelian Randomization Analysis of 98 085 Individuals From the General Population.
Çolak Y; Afzal S; Lange P; Nordestgaard BG
Nicotine Tob Res; 2019 Jul; 21(8):1036-1044. PubMed ID: 29688528
[TBL] [Abstract][Full Text] [Related]
12. Low-grade systemic inflammation: a partial mediator of the relationship between diabetes and lung function.
Giovannelli J; Trouiller P; Hulo S; Chérot-Kornobis N; Ciuchete A; Edmé JL; Matran R; Amouyel P; Meirhaeghe A; Dauchet L
Ann Epidemiol; 2018 Jan; 28(1):26-32. PubMed ID: 29223510
[TBL] [Abstract][Full Text] [Related]
13. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory markers and longitudinal lung function decline in the elderly.
Jiang R; Burke GL; Enright PL; Newman AB; Margolis HG; Cushman M; Tracy RP; Wang Y; Kronmal RA; Barr RG
Am J Epidemiol; 2008 Sep; 168(6):602-10. PubMed ID: 18687665
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation in young adults is associated with abnormal lung function in middle age.
Kalhan R; Tran BT; Colangelo LA; Rosenberg SR; Liu K; Thyagarajan B; Jacobs DR; Smith LJ
PLoS One; 2010 Jul; 5(7):e11431. PubMed ID: 20625390
[TBL] [Abstract][Full Text] [Related]
16. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland.
Thorleifsson SJ; Margretardottir OB; Gudmundsson G; Olafsson I; Benediktsdottir B; Janson C; Buist AS; Gislason T
Respir Med; 2009 Oct; 103(10):1548-53. PubMed ID: 19427181
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein mediates the association between leisure-time physical activity and lung function in middle-aged and older adults.
Chen M; Huang C; Feng W; Li Y; Wu Y
BMC Public Health; 2020 Jan; 20(1):6. PubMed ID: 31906909
[TBL] [Abstract][Full Text] [Related]
18. The dose-response association of urinary metals with altered pulmonary function and risks of restrictive and obstructive lung diseases: a population-based study in China.
Feng W; Huang X; Zhang C; Liu C; Cui X; Zhou Y; Sun H; Qiu G; Guo H; He M; Zhang X; Yuan J; Chen W; Wu T
BMJ Open; 2015 May; 5(5):e007643. PubMed ID: 25998037
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury.
Hart JE; Morse L; Tun CG; Brown R; Garshick E
J Spinal Cord Med; 2016 May; 39(3):344-52. PubMed ID: 26180939
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
